Jürgen Wess

Affiliations: 
NIDDK, National Institutes of Health 
Google:
"Jürgen Wess"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Balla H, Borsodi K, Őrsy P, et al. (2023) Intracellular signaling pathways of muscarinic acetylcholine receptor-mediated detrusor muscle contractions. American Journal of Physiology. Renal Physiology
Zheng F, Wess J, Alzheimer C. (2023) Long-Term-But Not Short-Term-Plasticity at the Mossy Fiber-CA3 Pyramidal Cell Synapse in Hippocampus Is Altered in M1/M3 Muscarinic Acetylcholine Receptor Double Knockout Mice. Cells. 12
Wess J. (2023) The third intracellular loop of GPCRs: size matters. Trends in Pharmacological Sciences
Meister J, Bone DBJ, Knudsen JR, et al. (2022) Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature Communications. 13: 22
Wess J. (2021) In Vivo Metabolic Roles of G Proteins of the Gi Family Studied with Novel Mouse Models. Endocrinology
Wang L, Zhu L, Meister J, et al. (2020) Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs. Annual Review of Pharmacology and Toxicology
Pydi SP, Jain S, Barella LF, et al. (2020) β-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia. Science Advances. 6: eaba1733
Wang L, Pydi SP, Zhu L, et al. (2020) Adipocyte G signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity. Nature Communications. 11: 2995
Zhu L, Rossi M, Doliba NM, et al. (2020) Beta-cell M muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs. International Immunopharmacology. 81: 106267
Dattaroy D, Barella LF, Pydi SP, et al. (2020) 2129-P: Glucagon Secretion from Pancreatic Islets Is Regulated by Beta-Arrestin-1 Diabetes. 69
See more...